基于网络的弱视决策支持工具
美国小儿眼病研究组召集专家组,综合147篇文献并在证据不足处采用共识,开发了免费网络弱视决策支持工具「弱视导航员」。该工具面向眼科医生和验光师,提供3至17岁弱视儿童的检查方法、屈光矫正、治疗选择、调整和随访建议,旨在促进早期发现和更广泛参与以改善视觉结局。
要点
- 工具基于147篇文献及专家共识,涵盖弱视诊断、屈光矫正、治疗和随访。
- 面向3至17岁弱视儿童,帮助非小儿专科的眼科医生和验光师规范管理。
- 目标是促进早期发现、扩大基层参与,最终改善弱视视觉结局。
核心结论
- 弱视常见且通常对治疗反应良好,决策支持工具有望通过促进早期发现和扩大基层眼科医生参与来改善视觉结局。
研究设计与样本
- 美国小儿眼病研究组召集专家组综合相关文献,在缺乏直接证据处采用共识,开发免费网络决策支持工具。
主要发现
- 工具呈现了所用流程、支持证据以及关于检查方法、屈光矫正、弱视治疗选择、治疗调整和监测时间表的建议。
关键数值与推荐
- 诊断措施、通过/转诊标准和管理建议基于147篇出版物。
- 证据缺乏时补充以临床试验方案或现有专业指南,数据冲突或不可用时通过委员会共识形成建议。
- 由单一评审员独立进行标准化(非系统性)文献回顾以避免遗漏相关近期出版物。
临床怎么用
- 眼科医生和验光师可借助该工具管理3至17岁弱视儿童,涵盖检查、屈光矫正、治疗调整和随访。
局限性
- 文献回顾由单一评审员完成且非系统性,部分建议基于共识而非直接证据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Amblyopia is the leading cause of monocular decreased best-corrected vision in children. Early detection and intervention are key for optimal treatment outcomes; however, limited access to pediatric eye specialists may hinder timely care and affect visual outcomes. Given the shortage of specialty-trained eye care professionals in the US, there is need to support comprehensive eye care professionals who are willing to examine and treat children with amblyopia. OBJECTIVE: A panel from the Pediatric Eye Disease Investigator Group synthesized relevant literature and incorporated consensus opinion where direct evidence was lacking to create the Amblyopia Navigator Decision-Support Instrument, a free, web-based amblyopia decision support tool for eye care professionals. EVIDENCE REVIEW: The decisions related to optimal diagnostic measures, pass/refer criteria, and management recommendations were informed by 147 publications. In areas where direct evidence was lacking, guidance was supplemented with clinical trial protocols or existing professional guidelines. When data were conflicting or unavailable, recommendations were established through committee consensus. A single reviewer independently performed standardized (though not systematic) literature reviews to avoid missing pertinent recent publications. FINDINGS: Presented are the process used, supporting evidence, and recommendations for testing methods, refractive correction, amblyopia treatment options, treatment adjustments, and monitoring schedules. CONCLUSIONS AND RELEVANCE: Because amblyopia is common and typically responds well to treatment, decision support tools that optimize its management could increase access to pediatric eye care by facilitating earlier detection, enabling broader participation of primary eye care professionals, and ultimately improving visual outcomes. Through this work and the development of the forthcoming free, web-based application version, Amblyopia Navigator Decision-Support Instrument, the Pediatric Eye Disease Investigator Group has created decision support tools designed to assist optometrists and ophthalmologists in the care of children aged 3 to 17 years with amblyopia.
引用
- Summers AI, Hatch SW, Hatt SR, et al. Web-Based Amblyopia Decision Support Tool. JAMA Ophthalmol. 2026. PMID: 42096234. doi:10.1001/jamaophthalmol.2026.1095
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。